Miele Medicine
Innovative pharmaceutical R&D solutions driving high-tech drug development and incubation
About Miele Medicine
Medinoah operates in the pharmaceutical research and development (R&D) sector, focusing on innovative drug development and incubation. The company serves pharmaceutical enterprises and research institutions, providing a comprehensive platform for drug R&D. Medinoah operates primarily in the high-tech pharmaceutical market, leveraging cutting-edge technology and scientific expertise to advance drug discovery and development. The business model revolves around offering R&D services and incubation support to pharmaceutical companies, generating revenue through service fees and collaborative partnerships. Medinoah's recognition as a National High-Tech Enterprise underscores its commitment to technological innovation and excellence in the pharmaceutical industry.
Source: Dealroom company dataNews
Open roles
Miele Medicine in the Suzhou Shi ecosystem
The Miele Medicine office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Oriza HoldingsAddor Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Miele Medicine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Miele Medicine on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
